Knowing how intraoperative anesthesia management and cardiac cycle monitoring affect postoperative cardiac outcomes in patients undergoing pancreatic surgery can help develop a protocol for future cases. Whether cardiac damage following non-cardiac surgery can be prevented and the necessary precautions are not yet clear, and the most important finding when it occurs is elevated troponin levels. This can occur even without ECG changes or chest pain. Prevention could contribute to a reduction in postoperative morbidity and mortality, and a shorter hospital stay. The primary aim of this study is to evaluate the correlation between the duration of cardiac cycle efficiency remaining below zero and increased troponin levels.
In patients undergoing non-cardiac surgery with cardiac risk factors, baseline values for preoperative troponin and pro-BNP are monitored as recommended by guidelines, followed by daily troponin monitoring for at least 3 days. Pancreatic surgeries are classified as high-risk surgeries by relevant guidelines, and cardiac output monitoring is recommended in this patient group with a Class 1A indication and evidence level. In this context, cardiac output monitoring with arterial wave analysis is routinely performed in our clinic, and the relevant parameters are followed. This observational study will examine the correlation between the intraoperative cardiac turnover trend and the highest troponin value within 3 days postoperatively. No specific intervention or protocol will be applied to the patients for this study. Preoperative troponin testing and postoperative troponin monitoring are recommended for patients over 65 years of age undergoing high-risk surgery, and for patients over 45 years of age with cardiac risk factors (history of cerebrovascular events, insulin-dependent diabetes mellitus, history of coronary artery disease, history of heart failure, serum creatinine \> 2 mg/dL, high-risk surgery). In general surgery clinics, this monitoring is routinely performed in this patient group, in accordance with the recommendations of relevant guidelines, to reduce perioperative morbidity/mortality.
Study Type
OBSERVATIONAL
Enrollment
51
Basaksehir Cam and Sakura City Hospital
Istanbul, Istanbul, Turkey (Türkiye)
Spearman correlation between cumulative intraoperative duration of CCE < -0.2 and postoperative hsTnT concentration
The primary outcome is the Spearman rank correlation coefficient (r\_s) between two measures: (1) cumulative intraoperative duration during which cardiac cycle efficiency (CCE) remains below -0.2, measured in minutes using the MostCare arterial waveform analysis system; and (2) high-sensitivity cardiac troponin T (hsTnT) concentration measured on the first postoperative morning, expressed in ng/L and determined using an electrochemiluminescence immunoassay (Roche Diagnostics). The correlation will quantify the strength and direction of the relationship between cumulative exposure to CCE \< -0.2 and postoperative hsTnT concentration.
Time frame: From the start of intraoperative hemodynamic monitoring to the first postoperative morning (approximately 24 hours after surgery).
Effective Arterial Elastance (Ea)
Effective arterial elastance (Ea) will be measured intraoperatively as a marker of arterial load. Its relative contribution to cardiac cycle efficiency (CCE) will be evaluated using hierarchical linear mixed-effects modeling. Model fit and the incremental contribution of Ea will be assessed using Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC).
Time frame: During surgery.
Total Arterial Impedance (Ztot)
Total arterial impedance (Ztot) will be measured intraoperatively as a marker of arterial load. Its relative contribution to cardiac cycle efficiency (CCE) will be evaluated using hierarchical linear mixed-effects modeling. Model fit and the incremental contribution of Ztot will be assessed using Akaike Information Criterion (AIC) and Bayesian Information Criterion (BIC).
Time frame: During surgery.
Cardiac Cycle Efficiency (CCE)
Cardiac cycle efficiency (CCE) will be assessed intraoperatively as a measure of the efficiency of cardiac mechanical work. CCE will be evaluated at predefined intraoperative time points and analyzed using linear mixed-effects modeling.
Time frame: During surgery
Stroke Volume (SV)
Stroke volume (SV) will be assessed intraoperatively as a measure of cardiac output per cardiac cycle and evaluated as a hemodynamic determinant of cardiac cycle efficiency using linear mixed-effects modeling.
Time frame: During surgery
Maximal Rate of Pressure Rise (dP/dtmax)
The maximal rate of ventricular pressure rise (dP/dtmax) will be assessed intraoperatively as a measure of myocardial contractility and evaluated as a hemodynamic determinant of cardiac cycle efficiency using linear mixed-effects modeling.
Time frame: During surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.